2023³â ´ëÇѵΰæºÎÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2023-06-10 |
|
2023³â ´ëÇѵΰæºÎÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2023-06-10 ±³À°ÁÖÁ¦ : 2023³â ´ëÇѵΰæºÎÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇѵΰæºÎÁ¾¾çÇÐȸ À̸ÞÀÏ : kshno@daum.net ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú Âü¼®¿¹»óÀÎ : 150¸í Áö¿ª : ´ë±¸±¤¿ª½Ã ¼¼ºÎ¼ö°·á : 110,000¿ø ºñ°í »çÀüµî·Ï ȸ¿ø:80,000¿ø ºñȸ¿ø:100,000¿øÇöÀåµî·Ï ȸ¿ø :90,000¿ø ºñȸ¿ø:110,000¿øÀü°øÀÇ °£È£»ç : 30,000¿ø
±âŸ 06¿ù 10ÀÏ Room1,2 07:00~08:00 Board Meeting () ±âŸ 06¿ù 10ÀÏ Room1,2 08:00~08:20 Registration () ±âŸ 06¿ù 10ÀÏ Room1,2 08:20~08:30 Opening remarks ÀåÇ×¼®,¼ÕÁøÈ£(¿¬¼¼ÀÇ´ë ¿Ü°ú/°æºÏ´ëÀÇ´ë À̺ñÀÎÈÄ°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 08:30~08:50 Surgical Extent and Knowhow to Minimize Postoperative Complications ÀÌ¿ë»ó(¿¬¼¼´ë ¿Ü°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 08:50~09:10 RAI Refractory Thyroid Cancer: Characteristics and Management ÀÌÀαâ(¿øÀڷº´¿ø ¹æ»ç¼±Á¾¾çÇаú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 09:10~09:30 Targeted Therapy À̼¿µ(¿¬¼¼ÀÇ´ë Á¾¾ç³»°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 09:30~09:50 Radiotherapy in Locally Recurrent or Metastatic Cancer ³ëÀç¸í(¼º±Õ°üÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 09:50~10:10 Radiofrequency Ablation for Locoregional Recurrence: When and How? Á¤»õ·Ò(¿ï»êÀÇ´ë ¿µ»óÀÇÇаú) ÈÞ½Ä 06¿ù 10ÀÏ Room1 10:10~10:30 ÈÞ½Ä () ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 10:30~10:50 Molecular Testing in Head and Neck Cancer ±èµ¿ÈÆ(¼º±Õ°üÀǴ뺴¸®°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 10:50~11:10 Surgeon Perspectives on Genomic Analysis and Decision Making ½É³²¼®(¿¬¼¼ÀÇ´ë À̺ñÀÎÈÄ°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 11:10~11:30 Incorporation of NGS to Clinical Practice for Head and Neck Cancer À̱â»Ý(¿¬¼¼ÀÇ´ë Á¾¾ç³»°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 11:30~11:50 Emerging Biomarkers in Head and Neck Cancer ¹Ú¼ÛÀÌ(Áß¾ÓÀÇ´ë Á¾¾ç³»°ú) Åä·Ð 06¿ù 10ÀÏ Room1 11:50~12:00 Åä·Ð () ½Ä»ç 06¿ù 10ÀÏ Room1 12:00~13:00 Á¡½É () ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 13:00~13:10 ºñÀÎµÎ¾Ï Áø´Ü°ú ÃßÀû °üÂûÀ» À§ÇÑ °¡À̵å¶óÀÎ Á¶Àç±Ù(ÀÎÁ¦ÀÇ´ë À̺ñÀÎÈÄ°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 13:10~13:20 Ãʱ⠺ñÀÎµÎ¾Ï Ä¡·á °¡À̵å¶óÀÎ ¿Àµ¿·Ä(¼º±Õ°üÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 13:20~13:30 ÁøÇ༺ ºñÀÎµÎ¾Ï Ä¡·á °¡À̵å¶óÀÎ ¹®¼ºÈ£ (±¹¸³¾Ï¼¾ÅÍ ¹æ»ç¼±Á¾¾çÇаú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 13:30~13:40 Àç¹ß/ÀüÀ̼º ºñÀÎµÎ¾Ï Ä¡·á °¡À̵å¶óÀÎ ÃÖ¿ë¿ø(¾ÆÁÖÀÇ´ë Á¾¾ç³»°ú) Åä·Ð 06¿ù 10ÀÏ Room1 13:40~14:00 µ¨ÆÄÀÌ () ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 14:00~14:20 Critical Diagnosis and Management of Primary Lesion ¿øÁ¾Çö(¿ï»êÀÇ´ë ÇǺΰú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 14:20~14:40 Elective Management of Neck ±¸º»¼®(Ãæ³²ÀÇ´ë À̺ñÀÎÈÄ°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 14:40~15:00 Systemic or Targeted Therapy ÃÖ¿ø¿µ(±¹¸³¾Ï¼¾ÅÍ Á¾¾ç³»°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 15:00~15:20 Aesthetic Reconstruction in Skin Cancer ±èµ¿¿¬(°¡Å縯ÀÇ´ë ¼ºÇü¿Ü°ú) Åä·Ð 06¿ù 10ÀÏ Room1 15:20~15:30 Åä·Ð () ÈÞ½Ä 06¿ù 10ÀÏ Room1 15:30~15:50 ÈÞ½Ä () ±³À°½Ã°£ 06¿ù 10ÀÏ Room1 15:50~17:30 Tumor board - Oral Cavity Cancer1. management of premalignant lesions 2. optical diagnosis for oral cavity cancer3. proper resection margins 4. decision making: reconstruction or not 5. postop. rehabilitation for OCC ±Ç¼ø¿µ ¿Ü 12(°í·ÁÀÇ´ë À̺ñÀÎÈÄ°ú ¿Ü 12) ±âŸ 06¿ù 10ÀÏ Room1 17:30~18:00 Adjourn / ½Ã»ó½Ä, ¸ÎÀ½¸» µî () ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 08:30~10:10 Anti-Thyroglobulin Antibody level in Thyroid Cancer Recur °íÀ±È£, ÀÌÀ±¼¼(°¡Å縯ÀÇ´ë Á¾¾ç³»°ú,¿ï»êÀÇ´ë À̺ñÀÎÈÄ°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 08:30~08:40 Anti-Thyroglobulin Antibody level in Thyroid Cancer Recur Á¤È£Áß(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 08:40~08:50 Tranoral robotic thyroidectomy vs transoral endoscopic thyroidectomy vestibular approach ÀÌÁؼº(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 08:50~09:00 Retropharyngeal node metastasis from thyroid cancer ±èÀºÁø(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 09:00~09:10 Early surgical outcomes of Single-port Robotic Thyroidectomy ±èÀºÁø(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 09:10~09:20 Depth of invasion and recurrence in small oral cavity cancer ¼ÛÁØ¿µ(¼¿ïÀÇ´ë) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 09:20~09:30 Clinical and Pathological Outcomes of TPF Induction Chemotherapy for Locally-Advanced Head and Neck Squamous Cell Carcinoma ±èÁÖ¸®(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 09:30~09:40 Head & Neck Cancer Risk Candidates in Alcohol Flush Group °º¸½Â(ÇѾçÀÇ´ë) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 09:40~09:50 Robot Parathyroidectomy With Primary Hyperparathyroidism ÀÌÁø¼®(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 09:50~10:00 Neoadjuvant Chemoradiotherapy on Anaplastic Thyroid Cancer ÀÌÁø¼®(¿¬¼¼ÀÇ´ô) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 10:00~10:10 Comparison of the approaches of robotic thyroidectomy ÀÌÁ¤ÈÆ(¾ÆÁÖÀÇ´ë ) ÈÞ½Ä 06¿ù 10ÀÏ Room2 10:10~10:30 ÈÞ½Ä () ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 10:30~10:45 Laser Therapy for Radiation-Induced Oral Mucositis Á¶Àοµ(¼øõÇâÀÇ´ë ¹æ»ç¼±Á¾¾ç³»°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 10:45~11:00 Rehabilitation of Treatment-Induced Dysphagia ¹ÚÁöÇý(°¡Å縯ÀÇ´ë ´ëÈ°ÀÇÇаú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 11:00~11:15 Psychological and Scial Rehabilitation ÀÌÁ¤Àç(´Ü±¹ÀÇ´ë Á¤½Å°Ç°ÀÇÇаú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 11:15~11:30 Surgical Management of Osteoradionecrosis Á¤¸¸±â(¼º±Õ°úÀÇ´ë À̺ñÀÎÈÄ°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 11:30~11:45 Aesthetic Outcomes After Head and Neck Cancer Surgery Á¤¿ì½Ä(¿ï»êÀÇ´ë ¼ºÇü¿Ü°ú) ½Ä»ç 06¿ù 10ÀÏ Room2 11:45~12:00 Åä·Ð () ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 14:00~14:20 The Role of Immunotherapy in Localized or Locally Advanced Head and Neck Cancer Á¤À¯¼®(±¹¸³¾Ï¼¾ÅÍ À̺ñÀÎÈÄ°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 14:20~14:40 Clinical Trials of Immunotherapy in Combination with Definitive (Chemo)Radiation ¼º¼öÀ±(°¡Å縯ÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 14:40~15:00 Updates in the Use of Immune Checkpoint Inhibitors for Metastatic/Recurrent Head and Neck Cancer Á¤ÁöÀ±(¿µ³²ÀÇ´ë Á¾¾ß³»°ú) ±³À°½Ã°£ 06¿ù 10ÀÏ Room2 15:00~15:20 Future Immunotherapies Beyond the Checkpoint Blockade »óÀ±¹ü(Â÷ÀÇ´ë Á¾¾ç³»°ú) Åä·Ð 06¿ù 10ÀÏ Room2 15:20~15:30 Åä·Ð ()
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|